These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9630961)

  • 1. Improved removal of viruslike particles from purified monoclonal antibody IgM preparation via virus filtration.
    Maerz H; Hahn SO; Maassen A; Meisel H; Roggenbuck D; Sato T; Tanzmann H; Emmrich F; Marx U
    Nat Biotechnol; 1996 May; 14(5):651-2. PubMed ID: 9630961
    [No Abstract]   [Full Text] [Related]  

  • 2. Clearance of murine leukaemia virus from monoclonal antibody solution by a hydrophilic PVDF microporous membrane filter.
    Aranha-Creado H; Peterson J; Huang PY
    Biologicals; 1998 Jun; 26(2):167-72. PubMed ID: 9811524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virus filtration of high-concentration monoclonal antibody solutions.
    Marques BF; Roush DJ; Göklen KE
    Biotechnol Prog; 2009; 25(2):483-91. PubMed ID: 19353736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of viral clearance unit operations for monoclonal antibodies.
    Miesegaes G; Lute S; Brorson K
    Biotechnol Bioeng; 2010 Jun; 106(2):238-46. PubMed ID: 20073086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane filtration for virus removal.
    Brandwein H; Aranha-Creado H
    Dev Biol (Basel); 2000; 102():157-63. PubMed ID: 10794103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigations into the fouling mechanism of parvovirus filters during filtration of freeze-thawed mAb drug substance solutions.
    Barnard JG; Kahn D; Cetlin D; Randolph TW; Carpenter JF
    J Pharm Sci; 2014 Mar; 103(3):890-9. PubMed ID: 24549732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Removal of virus through novel membrane filtration method.
    Manabe S
    Dev Biol Stand; 1996; 88():81-90. PubMed ID: 9119166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral clearance using disposable systems in monoclonal antibody commercial downstream processing.
    Zhou JX; Solamo F; Hong T; Shearer M; Tressel T
    Biotechnol Bioeng; 2008 Jun; 100(3):488-96. PubMed ID: 18438883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammalian cells and their contaminants.
    Minor PD
    Dev Biol Stand; 1996; 88():25-9. PubMed ID: 9119147
    [No Abstract]   [Full Text] [Related]  

  • 10. Removal of virus to protozoan sized particles in point-of-use ceramic water filters.
    Bielefeldt AR; Kowalski K; Schilling C; Schreier S; Kohler A; Scott Summers R
    Water Res; 2010 Mar; 44(5):1482-8. PubMed ID: 19926110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-step purification of murine monoclonal antibodies of the IgM class.
    Bouvet JP; Pirès R
    J Immunol Methods; 1991 Dec; 145(1-2):263-6. PubMed ID: 1765662
    [No Abstract]   [Full Text] [Related]  

  • 12. [Possibilities of material contamination due to additional injections].
    Müller-Stock A
    Klin Anasthesiol Intensivther; 1977; (14):114-20. PubMed ID: 926677
    [No Abstract]   [Full Text] [Related]  

  • 13. Improved antibody aggregate removal by hydroxyapatite chromatography in the presence of polyethylene glycol.
    Gagnon P
    J Immunol Methods; 2008 Jul; 336(2):222-8. PubMed ID: 18571666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hole story. Fine-pore membranes remove viruses from biological drugs.
    Erickson D
    Sci Am; 1992 Sep; 267(3):163-4. PubMed ID: 1502518
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection, purification, and utilization of murine monoclonal IgM antibodies.
    Walker ID
    Methods Mol Biol; 1995; 45():183-8. PubMed ID: 7550681
    [No Abstract]   [Full Text] [Related]  

  • 16. Virus removal from factor IX by filtration: validation of the integrity test and effect of manufacturing process conditions.
    Roberts PL; Feldman P; Crombie D; Walker C; Lowery K
    Biologicals; 2010 Mar; 38(2):303-10. PubMed ID: 20089418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomenclature standardization for 'large pore size' virus-retentive filters.
    Brorson K; Sofer G; Aranha H
    PDA J Pharm Sci Technol; 2005; 59(6):341-5. PubMed ID: 16471421
    [No Abstract]   [Full Text] [Related]  

  • 18. The clearance of viruses and transmissible spongiform encephalopathy agents from biologicals.
    Farshid M; Taffs RE; Scott D; Asher DM; Brorson K
    Curr Opin Biotechnol; 2005 Oct; 16(5):561-7. PubMed ID: 16095899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of virus removal in large scale purification processes.
    Fritsch E
    Dev Biol Stand; 1992; 76():239-48. PubMed ID: 1478342
    [No Abstract]   [Full Text] [Related]  

  • 20. Virological aspects of the quality control of human monoclonal antibodies.
    Minor P
    Dev Biol Stand; 1991; 75():233-6. PubMed ID: 1794626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.